Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Developing Chemical Genetic Approaches to Explore G Protein-Coupled Receptor Function: Validation of the Use of a Receptor Activated Solely by Synthetic Ligand (RASSL)

Elisa Alvarez-Curto, Rudi Prihandoko, Christofer S. Tautermann, Jurriaan M. Zwier, John D. Pediani, Martin J. Lohse, Carsten Hoffmann, Andrew B. Tobin and Graeme Milligan
Molecular Pharmacology December 2011, 80 (6) 1033-1046; DOI: https://doi.org/10.1124/mol.111.074674
Elisa Alvarez-Curto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudi Prihandoko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christofer S. Tautermann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jurriaan M. Zwier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Pediani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Lohse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Hoffmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew B. Tobin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme Milligan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 80 no. 6 1033-1046
DOI 
https://doi.org/10.1124/mol.111.074674
PubMed 
21880827

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 8, 2011
  • Accepted August 30, 2011
  • Published online November 18, 2011.

Article Versions

  • Earlier version (August 31, 2011 - 07:40).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Elisa Alvarez-Curto,
  2. Rudi Prihandoko,
  3. Christofer S. Tautermann,
  4. Jurriaan M. Zwier,
  5. John D. Pediani,
  6. Martin J. Lohse,
  7. Carsten Hoffmann,
  8. Andrew B. Tobin and
  9. Graeme Milligan
  1. Molecular Pharmacology Group, Institute of Neuroscience and Psychology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom (E.A.-C., J.D.P., G.M.); Department of Cell Physiology and Pharmacology, University of Leicester, Leicester England, United Kingdom (R.P., A.B.T.); Lead Identification and Optimization Support, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany (C.S.T.); Cisbio Bioassays, Codolet, France (J.M.Z.); and Department of Pharmacology and Toxicology, University of Wuerzburg, Wuerzburg, Germany (M.J.L., C.H.)
  1. Address correspondence to:
    Graeme Milligan, Wolfson Link Building 253, University of Glasgow, Glasgow G12 8QQ, Scotland, UK, E-mail: graeme.milligan{at}glasgow.ac.uk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2011 to May 2023

AbstractFullPdf
Aug 201124013
Sep 20112590158
Oct 201155076
Nov 201132822117
Dec 20112423246
Jan 20121086458
Feb 2012704336
Mar 2012912036
Apr 2012472437
May 2012662025
Jun 201238811
Jul 2012361819
Aug 201246818
Sep 2012391311
Oct 20125877
Nov 20124458
Dec 2012411231
Jan 20131006528
Feb 2013252525
Mar 2013341628
Apr 2013561723
May 2013421219
Jun 2013322212
Jul 2013122219
Aug 20132134
Sep 201337119
Oct 2013321016
Nov 201331910
Dec 201316912
Jan 20147168
Feb 201416712
Mar 2014241819
Apr 2014312422
May 201416816
Jun 20142479
Jul 201424614
Aug 20141795
Sep 20141378
Oct 201446118
Nov 2014282018
Dec 201430163
Jan 2015201324
Feb 201513107
Mar 201519155
Apr 20151657
May 2015171011
Jun 20152591
Jul 2015261313
Aug 20152595
Sep 201523204
Oct 20154155
Nov 2015414060
Dec 2015545165
Jan 2016413313
Feb 201638149
Mar 20162169
Apr 20162874
May 2016231610
Jun 2016191214
Jul 20161978
Aug 20163298
Sep 201619138
Oct 20165118
Nov 2016977
Dec 20163165
Jan 20171192
Feb 20173126
Mar 20174153
Apr 20171178
May 20175143
Jun 20171145
Jul 20170186
Aug 201711512
Sep 201761717
Oct 20172109
Nov 201711814
Dec 20178184
Jan 2018596
Feb 20189277
Mar 2018132511
Apr 201833612
May 201824210
Jun 20185207
Jul 201852026
Aug 20180155
Sep 2018376
Oct 201876811
Nov 201851110
Dec 20181125
Jan 201912814
Feb 20192118
Mar 20191258
Apr 20192616
May 20191116
Jun 20191438
Jul 201920411
Aug 201923210
Sep 201936312
Oct 20191955
Nov 20192134
Dec 20193233
Jan 20201220
Feb 20201721
Mar 2020711
Apr 20201211
May 2020921
Jun 2020648
Jul 20201612
Aug 2020311
Sep 2020610
Oct 20202315
Nov 20201622
Dec 20202213
Jan 202121101
Feb 20211285
Mar 20211921
Apr 20211954
May 20214195
Jun 202124101
Jul 20212522
Aug 20212042
Sep 20211650
Oct 20211160
Nov 20211745
Dec 20211201
Jan 20222432
Feb 20221110
Mar 20223364
Apr 20221455
May 20221598
Jun 20225621
Jul 20221666
Aug 20221363
Sep 20221630
Oct 20223521
Nov 20221857
Dec 20221500
Jan 20232891
Feb 2023552
Mar 20231630
Apr 2023635
May 2023864

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 80 (6)
Molecular Pharmacology
Vol. 80, Issue 6
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Developing Chemical Genetic Approaches to Explore G Protein-Coupled Receptor Function: Validation of the Use of a Receptor Activated Solely by Synthetic Ligand (RASSL)
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Muscarinic RASSL Function

Elisa Alvarez-Curto, Rudi Prihandoko, Christofer S. Tautermann, Jurriaan M. Zwier, John D. Pediani, Martin J. Lohse, Carsten Hoffmann, Andrew B. Tobin and Graeme Milligan
Molecular Pharmacology December 1, 2011, 80 (6) 1033-1046; DOI: https://doi.org/10.1124/mol.111.074674

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Muscarinic RASSL Function

Elisa Alvarez-Curto, Rudi Prihandoko, Christofer S. Tautermann, Jurriaan M. Zwier, John D. Pediani, Martin J. Lohse, Carsten Hoffmann, Andrew B. Tobin and Graeme Milligan
Molecular Pharmacology December 1, 2011, 80 (6) 1033-1046; DOI: https://doi.org/10.1124/mol.111.074674
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics